• Users Online: 3558
  • Print this page
  • Email this page
Year : 2023  |  Volume : 3  |  Issue : 2  |  Page : 35-38

The burden of occult hepatitis B virus infection in hepatocellular carcinoma in Nigeria

1 Department of Internal Medicine, Federal Medical Centre, Yenagoa, Bayelsa, Nigeria
2 Department of Internal Medicine, Jos University Teaching Hospital, Jos, Plateau, Nigeria

Correspondence Address:
Stella-Maris Chinma Egboh
Department of Internal Medicine, Federal Medical Centre, Yenagoa, Bayelsa
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ghep.ghep_34_22

Rights and Permissions

The WHO guideline advocates for hepatitis B surface antigen (HBsAg) as the initial diagnostic test for hepatitis B virus (HBV) infection. There are, however, patients who may have the persistence of viral DNA in the liver or blood despite having undetectable HBsAg; these patients also need to be accounted for, especially in endemic areas. These groups of patients are also at risk of developing hepatocellular carcinoma, and they need to be identified. We advocate for funding to support projects and research centers that are able to detect occult HBV infection. This will be valuable in the reduction of the occult transmission of HBV and reactivation of quiescent HBV.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded34    
    Comments [Add]    

Recommend this journal